Thomas Kerfoot & Co. v. Louis K. Liggett Co.

59 F.2d 80, 14 U.S.P.Q. (BNA) 107, 1932 U.S. Dist. LEXIS 1249
CourtDistrict Court, D. Massachusetts
DecidedMay 21, 1932
DocketNo. 3247
StatusPublished

This text of 59 F.2d 80 (Thomas Kerfoot & Co. v. Louis K. Liggett Co.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Thomas Kerfoot & Co. v. Louis K. Liggett Co., 59 F.2d 80, 14 U.S.P.Q. (BNA) 107, 1932 U.S. Dist. LEXIS 1249 (D. Mass. 1932).

Opinion

HALE, District Judge.

In this ease the plaintiff alleges that in the year 1915 it put on tho market an entirely novel pharmaceutical preparation to be used as an inhalant for tho relief of colds in the head.

That, upon putting’ this novel preparation on the market, it adopted the word “Vapex” as a trade-mark, and that under this mark the product has been continuously sold in England since July 7,1915, and in the United States since 1922.

That, at the time plaintiff adopted the mark “Vapex,” no person or firm in the United States had the right to use that mark or any other1 one resembling it, and that such word, or any word confusingly similar to it, had never been used in the United States or elsewhere by any other person for a similar preparation. ,

That the mark “Vapex” was registered in England on February 27, 1915.

That the mark was registered in the United States Patent Office on March 18, .1924, under No. 181,259.

That prior to the commencement of tho acts complained of, the plaintiff extensively advertised and used said trade-mark throughout the United States of America, and that it had built up a very large and valuable business and good will in the United States, which was a source of great profit

That prior to tho acts of infring’ement complained of, no other person or firm in the United States used a trade-mark or trade-name to designate a similar and competing preparation beginning with “Vap,” save for occasional cases of infringement which may have occurred.

That prior to the commencement of this action the defendant was duly notified of plaintiffs rights and of the fact that Vapox liad been registered in the United States Patent Office.

That in the early part of the year 3921, at which time plaintiff’s preparation sold under its trade-mark Vapex was well known in the Uniied Stales of America, plaintiff: negotiated in confidence with defendant for the sale of the formula and business in the United States, together with the trade-mark “Vapex,” and that later, when negotiations were broken off, the sample bottle of Vapex left with defendant vas returned with parts of its contents removed.

That in the year 1927 defendant began to sell a preparation similar to Vapex.

That prior to the commencement of this action defendant gave special inducements to the managers and clerks in its drug- stores to push the sale of the preparation Vapure.

That prior to tho commencement of this action clerks in defendant’s store sold Vapure on requests for Vapex by retail customers; that the defendant has passed off its Vapure preparation on purchasers who desired plaintiff’s preparation Vapex; that defendant has persuaded' prospective retail purchasers to take its preparation Vapure, by misrepresenting that Vapure and Vapex were owned by the same company, were the same products, and by many other misrepresentations.

That on discovering the confusion in the public mind and the defendant’s passing off arid misrepresentations, plaintiff notified defendant thereof and demanded that defendant discontinue tho misrepresentations and passing off and discontinue the use of the name “Vapure,” all of which defendant refused to do.

That by reason of the similarity of tho names “Vapex” and “Vapure,” the public has been deceived into- purchasing defendant’s preparation Vapure as and for plaintiff’s preparation Vapex.

That by reason of the passing off and misrepresentations, the public has been de-[82]*82eeived and induced to purchase Vapure for Vapex.

That' the name “Vapure” is a deceptive simulation and infringement of “Vapex,” and that the use of the name “Vapure” is calculated to and does cause clerks to pass off Vapure as and for plaintiff’s “Vapex,” and to make misrepresentations.

That by reason of these acts plaintiff’s business in its Vapex in the United States had been seriously injured, and plaintiff has been caused great damage.

That the name “Vapex” has acquired a ■meaning in the United States as indicating the unique preparation of the plaintiff.

That the acts of the defendant constitute unfair competition, in that the defendant has knowingly and willfully deceived the trade and public into purchasing its product Va-pure as and for Vapex, and has sold Vapure to customers who have been attracted by plaintiff’s advertising and did not clearly remember the name “Vapex” when they asked for that preparation.

That this court has jurisdiction over the action because it is brought by a foreign corporation against citizens of the United States, and because the action was brought to restrain an infringement of trade-mark registered in the United States Patent Office, and because the defendant has made large profits and caused the plaintiff great damage by reason of the acts complained of. And that such profits and damage exceed the sum of $100,000. That the value of the business and good will herein sought to be protected exceeds the sum of $100,000.

The defendant denies that it has competed unfairly with the plaintiff and that the public has been deceived or confused in the names “Vapure” and “Vapex” by any representations which it has made. It makes a substantial denial of plaintiff’s material al- . legations.

In eases of alleged infringement of trade-mark and unfair- competition, the ■courts hold that where rights to the exclusive use of the trade-mark are invaded the essence of the wrong consists in the sale of goods of one manufacturer and vendor as those of another; and it is only when this false representation is made that the party who appeals to the court for relief can have such relief. Delaware & H. Canal Co. v. Clark, 13 Wall. (80 U. S.) 311-322, 20 L. Ed. 581.

The plain question is, whether or not the plaintiff by a preponderance of evidence has proved its material allegation that by reason of the similarity of the names “Vapex” and “Vapure” and by unfair competition the public has been deceived or is likely to be deceived into purchasing Vapure, the preparation of the defendant, as and for plaintiff’s preparation, Vapex.

At the threshold of the ease important preliminary questions have been raised. I prefer to pass at once to the consideration of the vital question: Has’ the plaintiff proved unfair competition by a preponderance of evidence?

It appears from the testimony that in 1915 the plaintiff discovered and marketed in England a novel pharmaceutical preparation to be used as an inhalant for the treatment of colds and similar ills, to whieh.it gave the name of “Vapex.” This preparation came into public use in England, and in 1922 was introduced into this country and was continuously sold here subsequent to 1922.

It appears that the defendant owns a chain of drug stores throughout the United States. In most of its stores it sells a pharmaceutical product under the trade-mark “Vapure,” such trade-mark being registered in the United States Patent Office to the United Drug Company.

Products to which the marks “Vapex” and “Vapure” are applied are similar in their natures and in their use. It appears that Vapure is dealt in by many hundred stores throughout the United States which are commonly called “Rexall” stores, and which hold a contract with the United Drug Company for the distribution of goods manufactured by the United Drug Company.

Joseph B.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Canal Co. v. Clark
80 U.S. 311 (Supreme Court, 1872)
McLean v. Fleming
96 U.S. 245 (Supreme Court, 1878)
United States v. American Bell Telephone Co.
167 U.S. 224 (Supreme Court, 1897)
Bement v. National Harrow Co.
186 U.S. 70 (Supreme Court, 1902)
Howe Scale Co. v. Wyckoff, Seamans & Benedict
198 U.S. 118 (Supreme Court, 1905)
Continental Paper Bag Co. v. Eastern Paper Bag Co.
210 U.S. 405 (Supreme Court, 1908)
Saxlehner v. Wagner
216 U.S. 375 (Supreme Court, 1910)
Hanover Star Milling Co. v. Metcalf
240 U.S. 403 (Supreme Court, 1916)
United Drug Co. v. Theodore Rectanus Co.
248 U.S. 90 (Supreme Court, 1918)
Federal Trade Commission v. Klesner
280 U.S. 19 (Supreme Court, 1929)
Ely-Norris Safe Co. v. Mosler Safe Co.
7 F.2d 603 (Second Circuit, 1925)
Chadwick v. Covell
6 L.R.A. 839 (Massachusetts Supreme Judicial Court, 1890)
Flagg Manufacturing Co. v. Holway
59 N.E. 667 (Massachusetts Supreme Judicial Court, 1901)
Allen B. Wrisley Co. v. Iowa Soap Co.
122 F. 796 (Eighth Circuit, 1903)
Walter Baker & Co. v. Slack
130 F. 514 (Seventh Circuit, 1904)
G. W. Cole Co. v. American Cement & Oil Co.
130 F. 703 (Seventh Circuit, 1904)
Associated Press v. International News Service
240 F. 983 (S.D. New York, 1917)
Helfi Co. v. Silvex Co.
274 F. 653 (E.D. Pennsylvania, 1921)
Helfi Co. v. Silvex Co.
278 F. 613 (Third Circuit, 1922)
Ward Baking Co. v. Potter-Wrightington, Inc.
298 F. 398 (First Circuit, 1924)

Cite This Page — Counsel Stack

Bluebook (online)
59 F.2d 80, 14 U.S.P.Q. (BNA) 107, 1932 U.S. Dist. LEXIS 1249, Counsel Stack Legal Research, https://law.counselstack.com/opinion/thomas-kerfoot-co-v-louis-k-liggett-co-mad-1932.